View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 25, 2021

Health Catalyst to acquire SaaS technology company Twistle

Twistle can improve its automation with Health Catalyst’s cloud-based data platform DOS.

Health Catalyst has signed a definitive agreement to acquire US-based healthcare technology company Twistle for nearly $104.5m, plus a potential earn-out described below of up to $65m.

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

Twistle automates HIPAA-compliant communication between care teams and patients to transform the patient experience.

The combination of Twistle’s clinical workflow and patient engagement platform with the Health Catalyst population health offering is expected to enable a comprehensive go-to-market solution to address the needs of healthcare organisations.

Health Catalyst CEO Dan Burton said: “Twistle is a leading healthcare technology company committed to developing software that healthcare organisations and Life Science companies need to keep patients engaged in their healthcare.

“Their efforts to improve patient outcomes and reduce the cost of care are deeply aligned with our mission to be the catalyst for massive, measurable, data-informed improvements.”

With Health Catalyst’s cloud-based data platform DOS, Twistle will be able to improve its automation by enabling richer data-driven patient interaction.

Health Catalyst is expected to use a mix of stock and cash to fund the transaction.

Twistle founder and CEO Kulmeet Singh said: “Health Catalyst’s patient insights can trigger personalised outreach, and the patient’s unique profile will allow Twistle’s communication pathways to adapt to their preferences and attributes in unprecedented ways.

“We anticipate that care teams will realise even more efficiency gains as our automated outreach will be more intelligent and individualized, freeing their time to focus on patients that require intervention to stay on track with their medical plan of care.”

The transaction, which is subject to customary closing conditions, is slated for completion in the third quarter of this year.

Related Companies

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management